PPARGC1A and Headache: To further investigate whether Sirt3 and Pgc-1α are involved in the mechanisms of SS-31 on headache treatment, 3-TYP/SR-18292 was administered to inhibit the Sirt3/Pgc-1α after injection of SS-31 in an IS-induced mouse model.